Cambridge Financial Group’s Oracle ORCL Stock Holding History

Cambridge Financial Group’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24,375	Closed	-$4.75M	–	34
2025 Q4	$4.75M	Buy	+24,375	New	+$5.8M	1.81%	30

Other funds holding ORCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cambridge Financial Group's ORCL Position: Q1 2026 in Review

Cambridge Financial Group sold out of Oracle (ORCL) in Q1 2026, closing a stake of 24,375 shares — an estimated $4.75M sold.

Cambridge Financial Group first reported a position in ORCL in Q4 2025 and held it in 1 quarter. The position peaked at $4.75M in Q4 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

Cambridge Financial Group reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
Cambridge Financial Group sold 24,375 Oracle shares in Q1 2026, an estimated $4.75M.
Cambridge Financial Group first reported a position in Oracle in Q4 2025 and held it in 1 quarter.
Cambridge Financial Group's Oracle position peaked at $4.75M in Q4 2025.
3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Cambridge Financial Group's 13F filing for Q1 2026, filed 14 May 2026.